vs

Side-by-side financial comparison of IF Bancorp, Inc. (IROQ) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

IF Bancorp, Inc. is the larger business by last-quarter revenue ($7.3M vs $7.0M, roughly 1.0× Lakeside Holding Ltd). IF Bancorp, Inc. runs the higher net margin — 18.1% vs -22.6%, a 40.7% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 16.8%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

IROQ vs LSH — Head-to-Head

Bigger by revenue
IROQ
IROQ
1.0× larger
IROQ
$7.3M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+78.2% gap
LSH
95.0%
16.8%
IROQ
Higher net margin
IROQ
IROQ
40.7% more per $
IROQ
18.1%
-22.6%
LSH

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
IROQ
IROQ
LSH
LSH
Revenue
$7.3M
$7.0M
Net Profit
$1.3M
$-1.6M
Gross Margin
27.2%
Operating Margin
24.9%
-21.3%
Net Margin
18.1%
-22.6%
Revenue YoY
16.8%
95.0%
Net Profit YoY
8.9%
18.7%
EPS (diluted)
$0.41
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IROQ
IROQ
LSH
LSH
Q4 25
$7.3M
$7.0M
Q3 25
$7.3M
$6.1M
Q2 25
$6.9M
$6.3M
Q1 25
$6.4M
$3.8M
Q4 24
$6.3M
$3.6M
Q3 24
$6.2M
$4.1M
Q2 24
$5.7M
Q1 24
$5.4M
Net Profit
IROQ
IROQ
LSH
LSH
Q4 25
$1.3M
$-1.6M
Q3 25
$1.4M
$-1.4M
Q2 25
$1.4M
$-893.1K
Q1 25
$1.0M
$-1.1M
Q4 24
$1.2M
$-1.9M
Q3 24
$633.0K
$-1.3M
Q2 24
$431.0K
Q1 24
$708.0K
Gross Margin
IROQ
IROQ
LSH
LSH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
IROQ
IROQ
LSH
LSH
Q4 25
24.9%
-21.3%
Q3 25
26.0%
-20.8%
Q2 25
29.1%
-8.9%
Q1 25
21.7%
-28.2%
Q4 24
26.8%
-55.6%
Q3 24
13.7%
-32.5%
Q2 24
9.3%
Q1 24
17.6%
Net Margin
IROQ
IROQ
LSH
LSH
Q4 25
18.1%
-22.6%
Q3 25
19.0%
-22.2%
Q2 25
21.0%
-14.2%
Q1 25
15.8%
-28.2%
Q4 24
19.4%
-54.1%
Q3 24
10.2%
-32.7%
Q2 24
7.6%
Q1 24
13.1%
EPS (diluted)
IROQ
IROQ
LSH
LSH
Q4 25
$0.41
$-0.08
Q3 25
$0.43
$-0.09
Q2 25
$0.48
$-0.11
Q1 25
$0.31
$-0.14
Q4 24
$0.38
$-0.26
Q3 24
$0.20
$-0.18
Q2 24
$0.15
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IROQ
IROQ
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$8.8M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$87.4M
$12.2M
Total Assets
$830.4M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IROQ
IROQ
LSH
LSH
Q4 25
$8.8M
$1.6M
Q3 25
$8.0M
$4.5M
Q2 25
$20.1M
$5.0M
Q1 25
$8.9M
$1.5M
Q4 24
$5.9M
$1.1M
Q3 24
$7.8M
$2.7M
Q2 24
$9.6M
Q1 24
$16.1M
Total Debt
IROQ
IROQ
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
IROQ
IROQ
LSH
LSH
Q4 25
$87.4M
$12.2M
Q3 25
$84.5M
$7.0M
Q2 25
$81.8M
$2.8M
Q1 25
$78.9M
$749.8K
Q4 24
$75.9M
$1.6M
Q3 24
$78.8M
$3.6M
Q2 24
$73.9M
Q1 24
$72.4M
Total Assets
IROQ
IROQ
LSH
LSH
Q4 25
$830.4M
$24.3M
Q3 25
$862.3M
$18.6M
Q2 25
$887.7M
$14.4M
Q1 25
$879.1M
$9.9M
Q4 24
$885.1M
$9.8M
Q3 24
$893.4M
$10.8M
Q2 24
$887.7M
Q1 24
$905.0M
Debt / Equity
IROQ
IROQ
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IROQ
IROQ
LSH
LSH
Operating Cash FlowLast quarter
$1.8M
$-453.5K
Free Cash FlowOCF − Capex
$1.7M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$9.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IROQ
IROQ
LSH
LSH
Q4 25
$1.8M
$-453.5K
Q3 25
$-539.0K
$-4.0M
Q2 25
$6.8M
$-483.7K
Q1 25
$1.8M
$-238.3K
Q4 24
$-155.0K
$-530.2K
Q3 24
$2.2M
$-1.4M
Q2 24
$2.3M
Q1 24
$19.0K
Free Cash Flow
IROQ
IROQ
LSH
LSH
Q4 25
$1.7M
Q3 25
$-582.0K
Q2 25
$6.5M
$-497.4K
Q1 25
$1.8M
Q4 24
$-226.0K
$-560.5K
Q3 24
$2.1M
$-1.4M
Q2 24
$2.0M
Q1 24
$-67.0K
FCF Margin
IROQ
IROQ
LSH
LSH
Q4 25
23.7%
Q3 25
-7.9%
Q2 25
95.1%
-7.9%
Q1 25
28.2%
Q4 24
-3.6%
-15.6%
Q3 24
33.6%
-34.5%
Q2 24
35.7%
Q1 24
-1.2%
Capex Intensity
IROQ
IROQ
LSH
LSH
Q4 25
0.9%
Q3 25
0.6%
Q2 25
3.5%
0.2%
Q1 25
0.4%
0.0%
Q4 24
1.1%
0.8%
Q3 24
1.2%
0.1%
Q2 24
4.3%
Q1 24
1.6%
Cash Conversion
IROQ
IROQ
LSH
LSH
Q4 25
1.36×
Q3 25
-0.39×
Q2 25
4.69×
Q1 25
1.81×
Q4 24
-0.13×
Q3 24
3.42×
Q2 24
5.30×
Q1 24
0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IROQ
IROQ

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons